Jones W B
Department of Obstetrics and Gynecology, Cornell University Medical College, New York, New York.
J Reprod Med. 1987 Sep;32(9):653-6.
Low-risk metastatic gestational trophoblastic disease is highly curable with single-agent chemotherapy. Careful monitoring of the response to therapy is essential so that one can alter treatment when signs of drug resistance occur. Because some low-risk patients require complex chemotherapy and/or surgery before achieving remission, therapy should be directed by experienced clinicians at facilities where appropriate ancillary services are available.
低风险转移性妊娠滋养细胞疾病采用单药化疗治愈率很高。仔细监测治疗反应至关重要，以便在出现耐药迹象时能够改变治疗方案。由于一些低风险患者在实现缓解之前需要进行复杂的化疗和/或手术，因此治疗应由经验丰富的临床医生在具备适当辅助服务的机构进行指导。
